Cross-Sector entity

Sai Parenterals

Company
5

Of the tracked stories, 3 of 3 also mention Powerica, the most common co-covered peer. ipo accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 3 Cross-Sector stories that mention Sai Parenterals, all published on March 24, 2026.

3 verified stories tracked

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · Sai Parenterals

3 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Sai Parenterals

Of the tracked stories, 3 of 3 also mention Powerica, the most common co-covered peer. ipo accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 3 Cross-Sector stories that mention Sai Parenterals, all published on March 24, 2026.

Stories tracked
3
Sources per story
2

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Sai Parenterals. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Sai Parenterals 3

Finance ipo Neutral 5

Powerica and Sai Parenterals Launch IPOs Amid Indian Primary Market Surge

Two significant initial public offerings, Powerica and Sai Parenterals, opened for subscription today, aiming to raise a combined ₹1,509 crore. Powerica leads the charge with a ₹1,100-crore issue focused on its wind power portfolio, while Sai Parenterals seeks ₹409 crore to bolster its pharmaceutical operations.

2 sources